長期投資家のためのIR情報
バリュートレンド

【4282】EPSホールディングス 〔上場廃止〕
【上場廃止、2021年9月17日、MBO】CRO(臨床試験受託)、CSO(医薬品販売支援)。

売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2021.09 2021/08/03 Q3予 75,000 → 0.0% +7.4% 5,500 → 0.0% +14.6% 5,900 → 0.0% +18.0% 3,300 → 0.0% +26.9%
2021.09 2021/05/07 修正予 75,000 ↑ +7.4% +7.4% 5,500 ↑ +14.6% +14.6% 5,900 ↑ +18.0% +18.0% 3,300 ↑ +26.9% +26.9%
2021.09 2021/02/02 Q1予 69,800 → 0.0% 0.0% 4,800 → 0.0% 0.0% 5,000 → 0.0% 0.0% 2,600 → 0.0% 0.0%
2021.09 2020/11/05 当初予 69,800 - - - 4,800 - - - 5,000 - - - 2,600 - - -
2020.09 2020/11/05 実 66,689 ↑ +5.0% -8.0% 4,553 ↑ +51.8% -26.2% 4,978 ↑ +65.9% -21.2% 1,995 ↑ +59.6% -43.6%
2020.09 2020/08/04 Q3予 63,500 → 0.0% -12.4% 3,000 ↑ +100.0% -51.4% 3,000 ↑ +76.5% -52.5% 1,250 ↑ +4.2% -64.7%
2020.09 2020/05/08 Q2予 63,500 ↓ -12.4% -12.4% 1,500 ↓ -75.7% -75.7% 1,700 ↓ -73.1% -73.1% 1,200 ↓ -66.1% -66.1%
2020.09 2020/02/04 Q1予 72,500 → 0.0% 0.0% 6,170 → 0.0% 0.0% 6,320 → 0.0% 0.0% 3,540 → 0.0% 0.0%
2020.09 2019/11/07 当初予 72,500 - - - 6,170 - - - 6,320 - - - 3,540 - - -
2019.09 2019/11/07 実 69,009 ↑ +1.3% -4.2% 6,279 ↑ +10.2% -12.8% 6,271 ↑ +8.1% -14.7% 3,633 ↑ +21.1% -22.7%
2019.09 2019/08/01 Q3予 68,100 ↓ -5.4% -5.4% 5,700 ↓ -20.8% -20.8% 5,800 ↓ -21.1% -21.1% 3,000 ↓ -36.2% -36.2%
2019.09 2019/05/08 Q2予 72,000 → 0.0% 0.0% 7,200 → 0.0% 0.0% 7,350 → 0.0% 0.0% 4,700 → 0.0% 0.0%
2019.09 2019/02/01 Q1予 72,000 → 0.0% 0.0% 7,200 → 0.0% 0.0% 7,350 → 0.0% 0.0% 4,700 → 0.0% 0.0%
2019.09 2018/11/07 当初予 72,000 - - - 7,200 - - - 7,350 - - - 4,700 - - -
2018.09 2018/11/07 実 65,769 ↓ -0.3% -0.3% 7,193 ↑ +5.0% +5.0% 7,436 ↑ +6.2% +6.2% 4,388 ↑ +4.5% +4.5%
2018.09 2018/08/01 Q3予 66,000 → 0.0% 0.0% 6,850 → 0.0% 0.0% 7,000 → 0.0% 0.0% 4,200 → 0.0% 0.0%
2018.09 2018/05/01 Q2予 66,000 → 0.0% 0.0% - - - - 7,000 → 0.0% 0.0% 4,200 → 0.0% 0.0%
2018.09 2018/02/01 Q1予 66,000 → 0.0% 0.0% 6,850 → 0.0% 0.0% 7,000 → 0.0% 0.0% 4,200 → 0.0% 0.0%
2018.09 2017/11/07 当初予 66,000 - - - 6,850 - - - 7,000 - - - 4,200 - - -
2017.09 2017/11/07 実 60,482 → 0.0% +4.3% 7,591 → 0.0% +16.8% 7,809 → 0.0% +20.1% 4,663 → 0.0% +33.2%
2017.09 2017/10/31 修正予 60,482 ↑ +4.3% +4.3% 7,591 ↑ +16.8% +16.8% 7,809 ↑ +20.1% +20.1% 4,663 ↑ +33.2% +33.2%
2017.09 2017/08/01 Q3予 58,000 → 0.0% 0.0% 6,500 → 0.0% 0.0% 6,500 → 0.0% 0.0% 3,500 → 0.0% 0.0%
2017.09 2017/05/02 Q2予 58,000 → 0.0% 0.0% 6,500 → 0.0% 0.0% 6,500 → 0.0% 0.0% 3,500 → 0.0% 0.0%
2017.09 2017/02/01 Q1予 58,000 → 0.0% 0.0% 6,500 → 0.0% 0.0% 6,500 → 0.0% 0.0% 3,500 → 0.0% 0.0%
2017.09 2016/11/08 当初予 58,000 - - - 6,500 - - - 6,500 - - - 3,500 - - -
2016.09 2016/11/08 実 52,703 ↑ +0.4% +10.3% 6,224 ↑ +11.1% +31.6% 6,589 ↑ +9.8% +41.7% 3,966 ↑ +13.3% +74.7%
2016.09 2016/08/01 Q3予 52,500 → 0.0% +9.8% 5,600 ↑ +7.2% +18.4% 6,000 ↑ +9.1% +29.0% 3,500 ↑ +16.7% +54.2%
2016.09 2016/05/02 Q2予 52,500 → 0.0% +9.8% - - - - 5,500 → 0.0% +18.3% 3,000 → 0.0% +32.2%
2016.09 2016/04/26 修正予 52,500 ↑ +1.5% +9.8% 5,225 ↑ +10.5% +10.5% 5,500 ↑ +18.3% +18.3% 3,000 ↑ +32.2% +32.2%
2016.09 2016/02/01 Q1予 51,700 ↑ +8.2% +8.2% 4,730 → 0.0% 0.0% 4,650 → 0.0% 0.0% 2,270 → 0.0% 0.0%
2016.09 2015/11/06 当初予 47,800 - - - 4,730 - - - 4,650 - - - 2,270 - - -
2015.09 2015/11/06 実 45,202 ↑ +2.5% +2.5% 5,482 ↑ +18.5% +18.5% 5,362 ↑ +23.9% +23.9% 2,163 ↑ +11.7% +11.7%
2015.09 2015/08/03 Q3予 44,120 → 0.0% 0.0% 4,625 → 0.0% 0.0% 4,327 → 0.0% 0.0% 1,937 → 0.0% 0.0%
2015.09 2015/05/01 Q2予 44,120 → 0.0% 0.0% 4,625 → 0.0% 0.0% 4,327 → 0.0% 0.0% 1,937 → 0.0% 0.0%
2015.09 2015/02/02 Q1予 44,120 → 0.0% 0.0% 4,625 → 0.0% 0.0% 4,327 → 0.0% 0.0% 1,937 → 0.0% 0.0%
2015.09 2014/11/06 当初予 44,120 - - - 4,625 - - - 4,327 - - - 1,937 - - -
2014.09 2014/11/06 実 41,800 - - - 4,491 - - - 4,242 - - - 1,828 - - -
シェア ツイート
ページトップへ戻る